Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven Ketchum, Ralph T. Doyle, Rebecca A. Juliano, Lixia Jiao, Craig Granowitz, Jean‐Claude Tardif, Christie M. Ballantyne

New England Journal of Medicine, 2018

Brigham and Women's Hospital, Harvard University, Inserm, Baylor College of Medicine, Université Paris Cité, National Heart Hospital, Hôpital Bichat-Claude-Bernard, Délégation Paris 7, Royal Brompton Hospital, Assistance Publique – Hôpitaux de Paris, Lung Institute, University of Maryland, Baltimore, Emory University, Amarin (United States), Montreal Heart Institute, Université de Montréal, Houston Methodist

Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

3164

Citations

View on Google Scholar

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Abstract

Journal Details

Join JournalsHub

Welcome Back